Skip to main content
. 2022 Jan 11;2022:9578788. doi: 10.1155/2022/9578788

Figure 2.

Figure 2

(a) Receiver operating characteristics (ROC) curve analysis of serum miR-451 in all breast cancer patients. (b) ROC curve analysis of serum miR-506 in all breast cancer patients.